BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Clinical Outcome
25 results:

  • 1. clinical Significance of Decreased GPX1 Expression in Patients with Acute Myeloid Leukaemia (Non-M3).
    Liang X; Yao Y; Li H; Wei J; Wan C; Liu Z
    J Coll Physicians Surg Pak; 2021 Aug; 31(8):941-946. PubMed ID: 34320712
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Erythroleukemia: an Update.
    Weinberg OK; Arber DA
    Curr Oncol Rep; 2021 Apr; 23(6):69. PubMed ID: 33876292
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Megakaryocytic Clustering in Chronic Myeloid leukemia: Can it be a Predictor of clinical outcome?
    Mughal Z; Babar H; Ashraf S; Hamid A; Khokhar A; Qamar S
    J Coll Physicians Surg Pak; 2021 Jan; 31(1):34-38. PubMed ID: 33546530
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic mutation constellations in acute myeloid leukaemia and myelodysplastic syndrome.
    Iacobucci I; Mullighan CG
    Curr Opin Hematol; 2021 Mar; 28(2):101-109. PubMed ID: 33427759
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Philadelphia-Negative Myeloproliferative Neoplasms: Laboratory Workup in the Era of Next-Generation Sequencing.
    Zuo Z; Li S; Xu J; You MJ; Khoury JD; Yin CC
    Curr Hematol Malig Rep; 2019 Oct; 14(5):376-385. PubMed ID: 31388824
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Impact of the BCR-ABL1 fusion transcripts on different responses to Imatinib and disease recurrence in Iranian patients with Chronic Myeloid leukemia.
    Rostami G; Hamid M; Jalaeikhoo H
    Gene; 2017 Sep; 627():202-206. PubMed ID: 28627443
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The new frontier of epigenetic heterogeneity in B-cell neoplasms.
    Dominguez PM; Teater M; Shaknovich R
    Curr Opin Hematol; 2017 Jul; 24(4):402-408. PubMed ID: 28375986
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. IDH1, lipid metabolism and cancer: Shedding new light on old ideas.
    Bogdanovic E
    Biochim Biophys Acta; 2015 Sep; 1850(9):1781-5. PubMed ID: 25960387
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Translating genomic discoveries to the clinic in pediatric oncology.
    Glade Bender J; Verma A; Schiffman JD
    Curr Opin Pediatr; 2015 Feb; 27(1):34-43. PubMed ID: 25502895
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prognostic value of IDH1 mutations identified with PCR-RFLP assay in acute myeloid leukemia patients.
    Elsayed GM; Nassar HR; Zaher A; Elnoshokaty EH; Moneer MM
    J Egypt Natl Canc Inst; 2014 Mar; 26(1):43-9. PubMed ID: 24565682
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. ATRA + ATO: has a new standard of care been established in low-risk acute promyelocytic leukaemia?
    Breccia M; Cicconi L; Lo-Coco F
    Curr Opin Hematol; 2014 Mar; 21(2):95-101. PubMed ID: 24434605
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Biology and management of therapy-related acute promyelocytic leukemia.
    Lo-Coco F; Hasan SK; Montesinos P; Sanz MA
    Curr Opin Oncol; 2013 Nov; 25(6):695-700. PubMed ID: 24076582
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Assessment of selected markers of apoptosis and angiogenesis in chronic lymphocytic leukemia].
    Motyčková M; Smolej L; Andrýs C; Rezáčová V; Reháček V; Simkovič M; Belada D; Zák P
    Vnitr Lek; 2013 Sep; 59(9):782-93. PubMed ID: 24073950
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. FLT3 inhibitors: a story of the old and the new.
    Fathi A; Levis M
    Curr Opin Hematol; 2011 Mar; 18(2):71-6. PubMed ID: 21245757
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Familial chronic lymphocytic leukemia.
    Goldin LR; Slager SL; Caporaso NE
    Curr Opin Hematol; 2010 Jul; 17(4):350-5. PubMed ID: 20389242
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Impact of new prognostic markers in treatment decisions in acute myeloid leukemia.
    Schlenk RF; Döhner K
    Curr Opin Hematol; 2009 Mar; 16(2):98-104. PubMed ID: 19468271
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Advancements in the molecular pathogenesis of myelodysplastic syndrome.
    Epling-Burnette PK; List AF
    Curr Opin Hematol; 2009 Mar; 16(2):70-6. PubMed ID: 19468267
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia.
    Mrózek K; Marcucci G; Paschka P; Bloomfield CD
    Curr Opin Oncol; 2008 Nov; 20(6):711-8. PubMed ID: 18841055
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Molecular detection of BCR/ABL fusion gene in Saudi acute lymphoblastic leukemia patients.
    El-Sissy A; El-Mashari M; Bassuni W; El-Swaayed A
    J Egypt Natl Canc Inst; 2006 Jun; 18(2):109-16. PubMed ID: 17496935
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia: recent advances.
    Mrózek K; Döhner H; Bloomfield CD
    Curr Opin Hematol; 2007 Mar; 14(2):106-14. PubMed ID: 17255787
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.